Metraipolis › archive › dc_99368317cbfc

Sunitinib and Fenofibrate as Combination Therapy for MDR Glioblastoma: Insights from In Vitro and In Silico Studies — Europe PMC PMID:41930177

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41930177
DOI: 10.32604/or.2025.073371
License (as archived): solo-consultazione
Archived: 2026-11-04T02:12:57.206Z
SHA-256 of the archived text: 3185769103969d9ce1f2fc824276951e82747412c10038f7be75b98bb6152c22
Stable URL of this page: https://metraipolis.com/documento/dc_99368317cbfc

How to cite

Sunitinib and Fenofibrate as Combination Therapy for MDR Glioblastoma: Insights from In Vitro and In Silico Studies — Europe PMC PMID:41930177 — Europe PMC (en), https://europepmc.org/article/MED/41930177 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_99368317cbfc (Metraipolis archive dc_99368317cbfc, sha256 3185769103969d9ce1f2fc824276951e82747412c10038f7be75b98bb6152c22)

BibTeX

@misc{dc99368317cbfc,
  title = {Sunitinib and Fenofibrate as Combination Therapy for MDR Glioblastoma: Insights from In Vitro and In Silico Studies — Europe PMC PMID:41930177},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41930177},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_99368317cbfc; sha256 3185769103969d9ce1f2fc824276951e82747412c10038f7be75b98bb6152c22},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41930177. Agents can read the archived copy with the MCP tool read_document.